Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Pfizer launches portal for German healthcare professionals

Pfizermed.de will provide product information, training and patient materials

Pfizer Germany healthcare professionals portal

Pfizer Germany has launched an online portal that will offer healthcare professionals in the country services including training and downloadable patient materials.

The ärzteportal, or physician portal, also provides a full overview of Pfizer's product range and pipeline research, along with information on a number of different therapeutic areas.

The pharma company will use the Pfizermed.de portal, which requires doctors to log in using either DocCheck or a Pfizer user profile, to host product-related as well as 'product neutral' CME-accredited training.

The site contrasts with similar pharma websites run from the UK, among them Novartis' Gladstone and GlaxoSmithKline's health.gsk, which need separate, and clearly marked, sections for healthcare professionals and patients to remain compliant with the ABPI's Code of Practice.

2nd July 2012

From: Marketing

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CreateHealth.io

We connect companies to customers through online and offline events. Our proprietary customer insight platform, and expert staff in stakeholder...

Latest intelligence

blog-icon-webinar-storytelling.png
Webinar: The storytelling method that works for e-detailing
If you can involve healthcare professionals in a story, they will be more open to your arguments....
Certainly, not!
Conventional wisdom acknowledges the inevitability of uncertainty. And Socrates apparently said something about it too, so it must be right (“As for me, all I know is that I know...
Curbing the rise of drug resistance
The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance...